Comprehensive solutions for cancer research and drug discovery
April 1, 2025
To enhance our research capacity in the field of metabolic diseases, our institution has officially launched a state-of-the-art Metabolic Disease Research Platform built around the advanced EchoMRI™ body composition analysis system. The platform is now fully operational and provides high-throughput, high-precision, and non-invasive analysis for animal models of obesity, diabetes, and metabolic syndrome.
The EchoMRI system offers rapid, repeatable, and anesthesia-free measurements of fat mass, lean mass, and body water in small animals. As a globally recognized tool in metabolic phenotyping, it plays a crucial role in evaluating the progression of metabolic disorders and the efficacy of therapeutic interventions. The platform is compatible with diet-induced and genetically modified models, and integrates seamlessly with GTT/ITT, metabolic cages, and other experimental systems to support comprehensive metabolic studies.
We now offer a range of services including one-time testing, longitudinal tracking, and large-scale cohort studies, as well as customized metabolic profiling tailored to specific research projects. We warmly welcome collaborations with academic and industry partners.
Contact us to discuss how we can support your research needs.